Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
LTRN
Stock Latest News
Company Announcements
Lantern Pharma Showcases AI Platform for Rare Cancers
13d ago
8K
LTRN
Premium
The Fly
Lantern Pharma gets orphan drug designation for LP-284 from FDA
16d ago
LTRN
Premium
The Fly
Lantern Pharma’s treatment of soft tissue sarcoma granted orphan designation
21d ago
LTRN
Premium
The Fly
Lantern Pharma establishes India AI center to industrialize RADR platform
24d ago
LTRN
Premium
The Fly
Lantern Pharma announces LP-184 clinical trial met all primary endpoints
2M ago
LTRN
Premium
Company Announcements
Lantern Pharma’s Q3 2025: Clinical and AI Progress
3M ago
LTRN
Premium
Company Announcements
Lantern Pharma’s Earnings Call: Progress and Funding Needs
3M ago
LTRN
Premium
Company Announcements
Lantern Pharma Achieves Key Milestones in Q3 2025
3M ago
8K
LTRN
Premium
The Fly
Lantern Pharma management to meet virtually with Lake Street
3M ago
LTRN
Premium
Pre-Earnings
Is LTRN a Buy, Before Earnings?
3M ago
LTRN
Premium
The Fly
Lantern Pharma engages New to The Street for media program
3M ago
LTRN
Premium
The Fly
Lantern Pharma presents clinical data from LP-284
3M ago
LTRN
Premium
Company Announcements
Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors
3M ago
LTRN
Premium
Company Announcements
Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment?
3M ago
LTRN
Premium
Company Announcements
Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment
3M ago
LTRN
Premium
Company Announcements
Lantern Pharma Holds Annual Stockholders Meeting
5M ago
8K
LTRN
Premium
The Fly
Lantern Pharma announces LP-184 trial met all primary endpoints
5M ago
LTRN
Premium
The Fly
Lantern Pharma trading resumes
5M ago
LTRN
Premium
The Fly
Lantern Pharma trading halted, news pending
5M ago
LTRN
Premium
The Fly
Lantern Pharma announces completion of Type C meeting with FDA
5M ago
LTRN
Premium
Company Announcements
Lantern Pharma Reports Q2 2025 Earnings and Strategic Progress
6M ago
LTRN
Premium
The Fly
Lantern Pharma completes targeted enrollment for HARMONIC trial
6M ago
LTRN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
